Saturday 15th June
0715-0830 Abbott Breakfast Symposium
Structural heart in 2019 and beyond
Meeting Room 4
Biosense  Breakfast Symposium
EP - Emerging Technologies
Meeting Room 3 
 

 

Breakfast served
0715-0730

LAA occlusion for stroke prevention evidence, patient selection
Lars Søndergaard
0730-0755

Transcatheter mitral valve repair evidence, indication, case in the box
Rajesh Nair and Sanjeevan Pasupati
0755-0830

Breakfast served
0715-0730

Point-by-point PVI Qdot style
Andrew Martin
0745-0800

Emerging RF balloon technologies for PVI
Geoffrey Clare
0800-0815

The Implantable Cardioverter Defibrillator – are we there yet?
Iain Melton
0815-0830 

0900-1030 Multivessel Coronary Artery Disease -
PCI or CABG
Meeting Room 1
Acute Coronary Syndromes - MINOCA etc
Meeting Room 2
Heart Failure 
Meeting Room 3
 

Role of PCI in 2019 - utility and future of FFR
Ali Khan
0900 - 0920

CABG in 2019
Brecon Wademan
0920 - 0945

Case-based discussion
Malcolm Abernethy
0945 - 1000

Dual antiplatelet therapy in high-risk clinically stable coronary artery disease: A randomised controlled trial
Philip Adamson
1000 - 1015

Frailty in very elderly patients undergoing percutaneous coronary intervention for acute coronary syndromes
Bernard Wong
1015 - 1030

SCAD in 2019
Aniket Puri
0900 - 0920

Takotsubo syndrome
Christina Chan
0920 - 0940

MINOCA
Sean Coffey
0940 - 1000

Borderline coronary physiology – outcomes of patients with a negative instantaneous wave-free ratio
Charlotte Greer
1000 - 1015

Acute coronary syndrome incidence, procedures and mortality outcomes in New Zealand 2006-2016: ANZACS-QI 27 nationwide data linkage study
Tom Wang
1015 - 1030

The cardiac patient in ICU
James Moore
0900 - 0915

Cardio-oncology
Kate Clarke
0915 - 0930

Methamphetamine-associated cardiomyopathy versus other non-ischaemic cardiomyopathies: A case-controlled study
Tom Wang
0930 - 0945

Improving detection of familial dilated cardiomyopathy by systematic screening
Michael Stubbs
0945-1000

From the heart to heart failure: A short history
Hamid Ikram
1000-1030

 

 

 

Chairs:

Malcolm Abernethy, 
Harvey White 

Sarah Fairley,
Aniket Puri

Katherine Ferrier and Raffat Shameem

1030-1100 Morning Tea - Exhibition Hall
1100-1230 Electrophysiology
Meeting Room 1
Structural Heart Disease
Meeting Room 2
Prevention
Meeting Room 3
 
 

Tips and tricks for the 12-lead ECG,
and who to refer
Iain Melton
1100 - 1130

AF ablation - what the Generalist needs to know
Miguel Valderrabano
1130 - 1200

Implanted device secrets for non-EPs
Martin Stiles
1200 - 1230

 

Mitral valve and PTMC
Phillip Matsis
1100 - 1115

Mitral valve surgery for primary or secondary mitral valve disease: An eight-year comparative cohort study
Tom Wang
1115 - 1130

Results from the first hundred percutaneous patent foramen ovale closures in Christchurch
Cameron McAlister
1130 - 1145

Mitra clip results - is New Zealand missing out?
Lars Søndergaard
1145 - 1200

Tricuspid valve
Rajesh Nair 
1200 - 1215

In 10 years
Mark Webster 
1215 - 1230

Introduction
1100-1105

Heart failure in congenital adult population
Jane Hannah
1105-1125

LDL in the 2020's:
How low is too low?
Harvey White
1125-1150

Cardiac rehabilitation in New Zealand - moving forward with clinical exercise physiology
Sonja Dreyer and
Lukas Dreyer
1150-1210 

Managing health-related anxiety in cardiac rehabilitation
John Moffat
1210-1230

Chairs

 

Peter Ruygrok and
David Smyth

Tom Donoghue and
Janet Dunbar

1230-1330 Lunch - Exhibition Hall
1330-1500 Imaging
Meeting Room 1
Acute Coronary Syndromes - Contemporary Anti-Platelet Management  
Meeting Room 2

 

Artificial intelligence in echocardiography for standard clinical metrics
William Hewitt
1330 - 1345

Aortic stenosis for beginners
Andrew To
1345 - 1400

Aortic regurgitation
James Pemberton
1400 - 1415

Can non-invasive myocardial work index calculation improve the accuracy of exercise stress echocardiography?
Andrew Borrie
1415 - 1430

3D Echo
Alexander Sasse
1430 - 1445

Infiltrative cardiomyopathies
Josh Martin
1445 - 1500

Optimal DAPT in ACS - shorter, longer?
Harvey White
1330 - 1345

Optimal DAPT following PCI in stable CAD?
Jithendra Somaratne
1345 - 1400

Optimal antithrombotic therapy in ACS and AF?
Michael Williams
1400 - 1415

Antithrombotic strategy for patients with anticoagulation indication undergoing percutaneous coronary intervention: Meta-analysis of randomised controlled trials
Becky Liao
1415 - 1430

Contemporary audit of prescribing patterns
following coronary artery bypass grafting
Danting Wei
1430 - 1445

Should all patients post-CABG receive DAPT?
Gerry Devlin
1445 - 1500

  

Chairs:

Timothy O'Meeghan and
Gillian Whalley

Harvey White and 
Mike Williams

1500-1515
Conference Close - Meeting Room 1

 

 

Conference close
Alexander Sasse

 

© 2019 CSANZ | Conference is managed by The Conference Company

Designed & Developed by 72DPI